obesity drug news today glp-1 october 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 Chart: 1 in 8 Americans

In all observational studies, GLP-1 RAs were used as adjuncts to standard IIH care with nearly all patients also receiving acetazolamide

Thorens B

From the evidence currently available, it is possible that a 24-hour fluid diet will maximise the chances of reducing residual gastric contents to a safe level

Article CAS Google Scholar Wu, F

GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation and minimal side effects

Strategies on how to manage these and other side effects are described in more detail here: Figure 3 of this article and Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists